Teladoc Health Return on Equity (ROE) Growth & History (TDOC)

Teladoc Health's return on equity was −13.93% for fiscal 2025.

View full Teladoc Health company overview

Teladoc Health annual return on equity history

Teladoc Health annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20252025-12-31−13.93%+38.53 pp
20242024-12-31−52.46%−42.95 pp
20232023-12-31−9.51%+139.34 pp
20222022-12-31−148.85%−146.16 pp
20212021-12-31−2.69%+3.06 pp
20202020-12-31−5.74%+4.01 pp
20192019-12-31−9.75%+2.60 pp
20182018-12-31−12.35%+14.69 pp
20172017-12-31−27.04%+9.21 pp
20162016-12-31−36.25%+68.26 pp
20152015-12-31−104.51%

Teladoc Health return on equity trends

Over the last five fiscal years, Teladoc Health's return on equity decreased from −5.74% to −13.93%, a change of −8.18 percentage points. The latest reported quarter, Q2 2026, shows −2.94%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Teladoc Health source filings ↗

Community posts

It’s quiet here.

No posts about TDOC yet. Start the conversation.

Write the first post